Background: The apolipoprotein E (apoE) type s4 isoform specifies increased cerebral and cerebrovascular ac-
INTRODUCTION
The apolipoprotein E type s4 allele contributes to the genetic susceptibility underlying a large proportion (-60%) of typical, sporadic Alzheimer disease (1) (2) (3) (4) (5) . Correlations between genetic and neuropathological results indicate that the apolipoprotein E (apoE) type E4 isoform specifies increased cerebral (6-10) and cerebrovascular (1 1-13) accumulation of amyloid-13 protein Currently proposed mechanisms for the proamyloidogenic activity of apoE s4 include the possibility that apoE £4 might have a relatively greater propensity (compared with apoE £3) for modulating AP3 misfolding and fibrillogenesis (19) (20) (21) (22) (23) , although we recently observed equipotent profibrillogenic activities for native apoE s3 and £4 isoforms (Sweeney et al., submitted for publication). Alternatively, apoE £4 might be inferior to apoE e3 in some bioactivity related to modulation of Af clearance (7, 24) . Since both A,3 and apoE are secreted proteins, either of these mechanisms might be attributable to direct apoE/A,B interactions (2, 24) Preparation of Conditioned Media ApoE isoform-transfected RAW264 cells were used to generate conditioned media containing native apoE isoforms. Conditioned media containing apoE were prepared using Dulbecco's minimal essential medium, which in some cases was supplemented with 0.2% (w/v) bovine serum albumin. Media were harvested after a 24-hr conditioning period, and apoE isoform levels were determined by quantitative immunoblotting of conditioned media and serum standards containing apoE (Fig. 1) . ApoE concentrations were adjusted to 20 j,g/ml using medium conditioned by untransfected RAW264 cells as diluent. These apoE concentrations are within the range reported for human cerebrospinal fluid (26) . Ali 
RESULTS
Preferential association of AP31-40 with native apoE s3 was demonstrated using an experimental protocol based on immunoblotting of denaturant-resistant apoE/A,B complexes, as previously described by LaDu et al. (24) . In the current study, conditioned media containing native apoE isoforms were derived from stably transfected RAW264 macrophage cells. Human kidney 293 cells were used in the study by LaDu et al. (24) . Figure 2 illustrates typical results obtained from one of three independent experiments. A31-40 was incubated with either conditioned medium from control untransfected RAW264 cells (Fig. 2, Lanes 1 and 4) , apoE g3-transfected RAW264 cells (Fig. 2, Lanes 2 and 5 ), or apoE g4-transfected RAW264 cells (Fig. 2, Lanes 3 and 6). Following incubation, aliquots were removed, mixed with an equal volume of nonreducing Laemmli buffer, and boiled for 3 min prior to loading and separation by SDS-PAGE in a 10-20% tricine gel. Separated proteins were then electroblotted to nitrocellulose and probed with either antibody 6E10 (Fig. 2, left panel) against AP 1-17 or anti-apoE antibody (Fig. 2, 
right panel).
Free AP31-40 was visible as a diffusely migrating, 6E 10-immunoreactive species at the bottom of the gel, near the bromphenol blue tracking dye indicator (Fig. 2, left panel) . Using antibody 6E10, an apoE/Aj31-40 complex (Fig. 2, arrow- head) was detectable following co-incubation of Af3'-40 with apoE £3 (Fig. 2, Lane 2) , but not following co-incubation of Af31-40 with apoE £4 (Fig. 2, Lane 3) . As expected, apoE E3 and £4 were detected only in media from transfected RAW264 cells (Fig. 2, Lanes 5 and 6 ). An apoE s3/Af31-40 complex was also visible as the slowly migrating component of the apoE E3 band, as detected with the anti-apoE antibody (Fig. 2 (27) . Our RAW264-produced apoE isoforms are lipid-poor (6.0 ± 2.6 ,ug phospholipid/100 ,ug apoE), suggesting that denaturation of apoE during purification (27) is the most likely explanation for the results obtained by Strittmatter et al. (2) .
Since apolipoprotein E s4-related Alzheimer disease is the most prevalent molecular subtype of the disease identified to date (4, 5) , an elucidation of the molecular pathology resulting from the apolipoprotein E s4 genotype is particularly crucial. Along this line, the ability of apoE £4 to promote cerebral and cerebrovascular accumulation of AP3 (6-13) would appear to be an important clue, especially considering that genetically heterogeneous forms of Alzheimer disease foster A,B accumulation via at least three independent amyloidogenic pathways: excess A,B precursor expression (28) , excess Af3 generation (29) , or generation of aberrant, excessively aggregable AP (16, 30) .
Studies of AP3 levels and plaque accumulation in affected individuals support the notion that the role of apoE s4 in ,3-amyloidogenesis might involve a deficiency of A,B clearance. Soluble A,B levels in human cerebrospinal fluid are apparently unaffected by the apoE E4 allele (31).
Parenchymal amyloid plaque density (plaques/ mm2) is increased by apoE E4, while plaque size is increased in Down syndrome (32) . These data are consistent with a proposed model (32) (33) . This possibility is supported by recent evidence that apoE-deficient mice exhibit learning and memory deficits (34, 35) , even in the absence of consistent obvious structural neuropathology (35 
